Scientific job: CLAIMED. The Cardiovascular Medicine Web retains ownership of cardiovascular disease and arrhythmias broadly. This article owns the narrower rhythm-intervention movement from palpitation/syncope/rhythm concern → ECG or ambulatory rhythm capture → symptom–rhythm correlation → arrhythmia classification → electrophysiology study and intracardiac mapping where needed → cardioversion/ablation/pacing/ICD pathway → rhythm/device interrogation → recurrence and rhythm-burden return. The Medical Devices Web retains long-term device identity, recalls and post-market safety.
Wait, what? A normal ECG can be perfectly true—and still miss the rhythm problem.
Many arrhythmias are intermittent. A person can experience palpitations, dizziness or fainting during an abnormal rhythm and have a normal electrocardiogram later. Cardiac Electrophysiology therefore treats time as part of the diagnostic object: symptoms have to be linked to the rhythm that existed when they occurred.
The National Heart Centre Singapore’s Electrophysiology & Pacing service currently manages complex arrhythmias using electrophysiology studies, catheter ablation, permanent pacemakers, cardiac resynchronisation devices, implantable cardioverter-defibrillators and ongoing device interrogation. That is a distinct treatment-and-measurement tube inside broader Cardiovascular Medicine.
The cardiac-rhythm tube
Symptom/rhythm concern → emergency gate → surface ECG and/or longer rhythm monitoring → symptom–rhythm correlation → classify brady/tachy/irregular/conduction problem → structural/medical contributors assessed → EP study/mapping where needed → medicine/cardioversion/ablation/pacing/ICD pathway → post-procedure/device interrogation → recurrence or rhythm-burden monitoring → long-term cardiovascular return.
1. Rhythm is a time-series object
A resting ECG is a short recording. Holter, patch, event and other ambulatory monitors extend observation across hours, days or longer depending on the clinical question. The purpose is not merely to collect more beats; it is to increase the chance that the electrical state is recorded during symptoms or clinically important episodes.
For eduKateAI, every rhythm result should preserve recording method, date/time, symptom state, heart rate/rhythm interpretation, duration of episode and whether the patient felt symptoms at that moment.
2. Palpitation is a symptom, not an arrhythmia diagnosis
Palpitations can occur during sinus tachycardia, premature beats, atrial fibrillation, supraventricular tachycardia, ventricular arrhythmia or even normal rhythm perceived more strongly. Anxiety, fever, anaemia, thyroid disease, stimulants and other non-cardiac states can also change heart-rate perception.
The anti-collapse rule is: palpitation ≠ arrhythmia automatically.
3. Syncope is a risk-routing problem
Loss of consciousness can arise from reflex fainting, orthostatic causes, seizure, metabolic disturbances or dangerous cardiac rhythm abnormalities. A normal rhythm after recovery does not necessarily exclude a transient arrhythmic cause.
Neurology may own seizure or other neurological causes; Cardiovascular Medicine owns haemodynamic disease; Cardiac Electrophysiology owns whether intermittent rhythm or conduction disturbance explains the event.
4. Bradycardia and tachycardia are categories, not final diagnoses
A slow heart rate can be physiological, medication-related or due to sinus-node or conduction disease. A fast rhythm can originate above or below the ventricles and may have very different risk. Classification therefore depends on rhythm mechanism, symptoms, structural heart state and context.
For eduKateAI: fast ≠ dangerous automatically and slow ≠ benign automatically.
5. Atrial fibrillation is both a rhythm and a stroke-risk state
Atrial fibrillation can be episodic or persistent and may cause palpitations, breathlessness, fatigue or no symptoms. Its importance is not limited to rhythm discomfort because it can also change thromboembolic risk and long-term cardiac function.
Cardiovascular Medicine owns the wider stroke-risk and disease trajectory. Electrophysiology owns the rhythm-control question: what rhythm strategy, monitoring, cardioversion or ablation pathway is appropriate?
6. Electrophysiology study makes the heart’s wiring experimentally observable
An electrophysiology study places intracardiac electrodes through catheters to record and stimulate electrical activity within the heart. The objective can include identifying an abnormal conduction pathway, reproducing an arrhythmia, locating its origin and deciding whether ablation is feasible.
For eduKateAI: surface ECG ≠ intracardiac map. They are different levels of electrical evidence.
7. Mapping turns an arrhythmia into a spatial target
Some arrhythmias arise from abnormal circuits, focal triggers or accessory pathways. Intracardiac mapping attempts to identify the electrical tissue involved so treatment can target the mechanism rather than simply slow the heart globally.
This creates a Science-to-Medicine bridge: bioelectric signalling belongs to physiology; authorised electrophysiology teams use measured activation patterns to create a patient-specific treatment target.
8. Catheter ablation is an electrical intervention
Catheter ablation deliberately modifies small regions of tissue involved in an arrhythmia circuit using an authorised energy source or technique. NHCS currently provides radiofrequency ablation and other contemporary rhythm interventions for selected arrhythmias.
Interventional Radiology does not own this merely because catheters are used. Cardiac Electrophysiology owns the electrical mapping and rhythm-target intervention.
9. Technical ablation success is not the same as long-term rhythm success
An arrhythmia may terminate during a procedure yet recur later. Conversely, an early post-procedure episode may not always represent long-term failure depending on the condition and treatment. Follow-up therefore requires rhythm monitoring, symptoms and sometimes repeat intervention.
For eduKateAI: arrhythmia terminated in lab ≠ recurrence risk eliminated.
10. Pacemakers treat timing and conduction failure
Permanent pacemakers can support patients whose intrinsic heart rate or conduction is too slow or unreliable. Device settings influence how and when pacing occurs and can be adjusted over time as physiology changes.
The Device Safety Web owns manufacturer/model/serial identity, recall and post-market lifecycle. Cardiac Electrophysiology owns why pacing is needed, how it is programmed for rhythm care and what interrogation shows about the patient’s electrical state.
11. ICDs are not simply “stronger pacemakers”
Implantable cardioverter-defibrillators can detect selected dangerous ventricular arrhythmias and deliver therapies intended to terminate them. Some devices also provide pacing. Their primary clinical job can therefore differ sharply from ordinary bradycardia pacing.
For eduKateAI: pacemaker ≠ ICD, and device present ≠ device therapy delivered.
12. Device interrogation is a rhythm record
Modern pacemakers and defibrillators can store information about detected rhythms, pacing percentage, battery state, lead performance and delivered therapies. NHCS’s arrhythmia and pacemaker clinic explicitly provides interrogation of implanted pacemakers and defibrillators.
This makes the device both treatment and sensor. The interpretation should preserve device identity + programmed settings + detected episode + electrogram evidence + therapy delivered + patient symptom context.
13. A device alert does not automatically mean the patient had a clinical event
Devices can detect noise, oversensing, non-sustained rhythms or episodes that require specialist interpretation. Likewise, symptoms may occur without a device-recorded arrhythmia.
The anti-collapse rule is: device detection ≠ final clinical diagnosis automatically.
14. Antiarrhythmic medicines and procedures remain linked
Some patients are managed primarily with medicines; others undergo ablation or device therapy; many move between approaches. Kidney/liver function, QT effects, drug interactions and structural heart disease can alter pharmacological choices.
Pharmacy owns medicine identity and safety. Therapeutic Drug Monitoring may apply to selected medicines. Electrophysiology owns whether the rhythm strategy is working and whether electrical risk remains acceptable.
15. Rhythm burden can matter more than a binary yes/no diagnosis
Intermittent arrhythmias can vary in frequency, duration and symptom burden over time. A patient can remain diagnosed with a rhythm disorder while episode burden falls substantially after treatment.
For eduKateAI, useful longitudinal fields include episode count, duration, longest episode, symptom association, ventricular rate, treatment changes and recurrence after intervention where clinically available.
16. Sudden cardiac death risk changes the urgency
Some inherited or acquired electrical disorders can increase risk of malignant ventricular arrhythmia. Genetics may become relevant in conditions such as inherited channelopathies, while family evaluation can sometimes be required.
Genetics/Genomics owns variant interpretation; Cardiac Electrophysiology owns how that information changes rhythm surveillance and device/ablation decisions.
17. Ablation or device implantation does not end cardiovascular care
Hypertension, heart failure, valve disease, coronary disease, sleep apnoea, obesity and other conditions can influence arrhythmia recurrence and long-term outcome. The patient therefore returns to broader Cardiovascular Medicine and Primary Care after the rhythm-specific intervention.
The final receipt is not “procedure done”. It is rhythm burden reduced or controlled + symptoms/function reassessed + device/recurrence monitoring active + underlying cardiovascular risks still owned.
Characteristic failure modes
- Palpitation = arrhythmia error: symptom becomes diagnosis without rhythm capture.
- Normal ECG = no arrhythmia error: intermittent rhythm disorder is excluded by a short recording.
- Fast = dangerous error: rate is treated as risk without mechanism/context.
- EP study = ordinary ECG error: intracardiac electrical mapping and surface recording collapse together.
- Ablation success = cured forever error: recurrence monitoring disappears.
- Pacemaker = ICD error: devices with different rhythm jobs are merged.
- Device alert = clinical event error: stored signal is accepted without specialist interpretation.
- Procedure = whole cardiovascular care error: underlying heart disease and risk factors vanish after intervention.
The eduKateAI routing contract
- Canonical public owner: Cardiac Electrophysiology & Rhythm Management Web.
- Input state: suspected/known arrhythmia, syncope possibly due to rhythm disturbance, EP study/ablation decision or pacemaker/ICD rhythm-management pathway.
- Primary job: preserve symptom–rhythm timing, electrical classification, EP mapping/intervention, device interrogation and recurrence burden.
- Do not collapse: palpitation ≠ arrhythmia; normal brief ECG ≠ no intermittent arrhythmia; pacemaker ≠ ICD; technical procedure success ≠ long-term rhythm control.
- Handoffs: Cardiovascular Medicine, Emergency/Critical Care, Pharmacy, Medical Devices/Post-Market Safety, Genetics/Genomics, Sleep Medicine, Laboratory Medicine and relevant surgical services.
- Return receipt: rhythm captured/not captured, mechanism classified/uncertain, EP intervention performed/not needed, device programmed/interrogated, recurrence burden improved/unchanged/worsened, cardiovascular follow-up accepted.
Authoritative routes
- National Heart Centre Singapore — Electrophysiology & Pacing
- National Heart Centre Singapore — Electrophysiology & Pacing training scope
Educational boundary: this article explains cardiac-electrophysiology and rhythm-management information architecture. It does not interpret an ECG or device interrogation, diagnose an arrhythmia, determine whether ablation/pacing/ICD treatment is appropriate or provide management advice for palpitations, syncope or implanted devices.